Computational Biology Market Analysis, Industry Size, Share, Application Analysis, Regional Outlook, Growth, Trends, Competitive Scenario and Segment Forecasts, 2012 to 2020

Hexa Reports

Market Research Reports and Insightful Company Profiles

Computational Biology Market Analysis, Industry Size,

Share, Application Analysis, Regional Outlook, Growth,

Trends, Competitive Scenario And Segment Forecasts, 2012

To 2020

The global market for computational biology is expected to reach USD 4,285.1 million by 2020 growing

at a CAGR of 21.1%. Steady increase in the usage & application of computational biology for

bioinformatics R&D programs designed for sequencing genomes to better understand biological systems

and increasing number of clinical studies in pharmacogenomics and pharmacokinetics for novel drug

discovery studies are expected to drive computational biology demand over the next six years.

Computational genomics for cellular and biological simulation applications dominated the market in

2013, accounting for over 47% of global revenue. Key factors driving demand for these applications

include the growth of drug designing, disease modeling and personalized medicine applications and the

growing usage of computational biology for functional and structural genomics, epigenomics and

metagenomics for the analysis of protein transcription, protein-protein interactions, gene sequencing

and expression and 3-dimensional protein structure analysis.

Browse Detail Report With TOC @ http://www.hexareports.com/report/computational-biologymarket/

Further key findings from the study suggest:

North America was the largest regional market, accounting for 58.0% of the global revenue in 2013. Its

large share is majorly attributed to the growing research investments and initiatives for development of

Hexa Reports

Market Research Reports and Insightful Company Profiles

drug discovery, disease modeling technologies and innovations in biological computation methods. It is

expected that Asia Pacific will witness the fastest growth in the market, at an estimated CAGR of 28.0%

owing to the increasing expenditure in clinical studies for pharmacokinetics and...